Enlighten Spokane

06/21/2026

🍄‍🟫 Documentary Film Screening in Spokane - The Next Chapter: Psychedelics, Healing, and the Second Half of Life 🍄‍🟫

Hello Psychedelic Community,

Mark your calendars! I am happy to share a documentary film screening to be held on Sept 26th, from 5-9 pm (to allow community time before/after), at the Magic Lantern Theatre in Spokane. The seating capacity is approximately 100. The film is 37 minutes long. There will be a panel discussion after the film concludes.

Watch the teaser here:
https://www.youtube.com/watch?v=P1O2XaFBpsM

As for ticket cost, the hope is that a gratitude tier for pricing will be offered to allow individuals to select what they feel comfortable with, somewhere between $15-30.

Film at a Glance:
An intimate documentary following adults over 55 as they turn to psychedelic-assisted therapy to meet depression, anxiety, grief, and the unfinished work of a lifetime — and to discover whether it is ever too late to begin again. Through intimate, story-driven portraits, the film looks beyond the science to the human experience of healing later in life.

I recently had a call with Kelly McGinty and Kendra Branch (see Kendra's bio, attached; Kelly's is below). They are the Co-Founders of Trip Hōm (https://triphom.com/). This org, as a collective, is the executive producer of the film. Kelly is also a co-author of the book, Mycelopause. Both are wonderful humans, and I would love for you to meet them during this event.

Kelly's bio:
Kelly McGinty, FNP, is a nurse practitioner with over a decade of experience in emergency medicine, trained at Gonzaga University and board-certified through the American Academy of Nurse Practitioners. Witnessing the mental health toll of the pandemic, she expanded her work beyond conventional care to include holistic and psychedelic-assisted approaches. Trained through the California Institute of Integral Studies (CIIS), Kelly integrates Western medicine with functional health, nature-based practices, Reiki, and plant medicine to support the healing of mind, body, and spirit.

I hope to see you at the screening!

06/21/2026

“The report is centered on a Japanese-American woman in her 80s whose Alzheimer’s had progressed for a decade. For around five years, she communicated mostly in single syllables. She needed constant care. She struggled to walk. She suffered from chronic urinary incontinence. And then, she was given a five-gram dose of mushrooms containing psilocybin. Around 19 hours later, she woke up and started speaking in complete sentences, all the while recalling details from her life for nearly four hours, as if the years of being locked in her brain had made her antsy to speak again.”

Researchers caution it’s only one case, but the report raises questions about whether psilocybin could restore dormant brain functions.

06/14/2026

Let’s make this happen in Spokane!

Portland’s city council is considering an ordinance to make personal use of psilocybin mushrooms a low police priority.



The Portland Psychedelic Society has been pushing city officials to take up the ordinance.

06/14/2026

Psilocybin-assisted therapy reduced anxiety across 25 studies.

Abstract Background and Aims Psilocybin-assisted psychotherapy (PAP) is a novel, transdiagnostic treatment in which the 5-HT2A receptor agonist psilocybin is combined with psychotherapy. Studies to date have evaluated PAP's effects on depression, substance use, and end-of-life adjustment. Relatively...

06/07/2026

This is what professional, legal psilocybin mushroom cultivation looks like, from grain to harvest.

Ever wondered what it looks like to grow magic mushrooms at scale? We recently visited Lost Garden Labs and Therapeutics in Colorado to document their cultiv...

06/07/2026

Louisiana lawmakers sent a bill to create a psychedelic-assisted therapy pilot program, funded by opioid settlement dollars, to the governor.

Louisiana lawmakers have sent the governor a bill to create a psychedelic-assisted therapy pilot program, using opioid settlement dollars to fund clinical trials aimed at developing alternative treatments such as psilocybin, ibogaine and M**A. The Senate signed off the final version of the proposal....

06/07/2026

The largest psychedelic trial yet found that one or two doses of psilocybin with psychotherapy produced antidepressant effects for up to a year.

05/31/2026

Attorneys are pressing the DEA to reschedule psilocybin, especially after Trump’s executive order made the delay harder to justify.

The Drug Enforcement Administration (DEA) is being put on notice—again—over prolonged delays in processing a petition to reschedule psilocybin from a doctor who wants to use it to treat terminally ill patients, with an updated reminder that President Donald Trump has now made clear his administr...

05/17/2026

Anthropologists confirmed the first known case of traditional psilocybin use outside the Americas.

Reliable documentation of the traditional use of serotonergic psychedelics has long been confined to the Americas. Prevailing narratives often overstate the global prevalence and uniformity of traditional psychedelic use, extrapolating from a limited set of well-documented cases. Here, we report evi...

05/17/2026

30 bipartisan U.S. House members cosigned a letter to the FDA requesting clarity on its response to the psychedelics executive order.

Millions of Americans continue to struggle with complex mental health challenges, and for many, existing treatment options fall short. This gap in care is felt acutely among Veterans, who experience rates of PTSD, depression, and su***de far exceeding those of the general population, and it has cont...